Thyroid peroxidase antibodies and their role in predicting outcomes in Graves’ disease treatment
Anti-TPO positivity at diagnosis of GD did not affect the relapse rate after ATD treatment but could be associated with a better long-term effect of RI. Anti-TPO did not increase the risk of hypothyroidism post-ATD therapy. Understanding risk factors of relapse or hypothyroidism can facilitate treatment choices and help physicians individualize management and follow-up strategies for patients with GD.
Authors
- Geriolda Topi (ORCID: https://orcid.org/0000-0002-1103-2513)
- Jan Calissendorff (ORCID: https://orcid.org/0000-0003-2088-5814)
- Tereza Planck (ORCID: https://orcid.org/0000-0003-1398-5067)
- Klara Gewert
Institutions
- Karolinska University Hospital (SE)
- Lund University (SE)
- Karolinska Institutet (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.3389/fendo.2025.1517283
- Citations
- 1
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Karolinska Institutet